Most Read This Week
- Next-Generation Oral SERD Camizestrant vs Fulvestrant in Postmenopausal ER+/HER2− Advanced Breast Cancer
- Comparison of First-Line Chemotherapy Regimens in Unresectable Locally Advanced or Metastatic Pancreatic Cancer
- Stereotactic Body Radiotherapy for Localized Prostate Cancer
- The Lancet Breast Cancer Commission: Evidence-Based Roadmap to Address Urgent Global Breast Cancer Challenges
- Long-Term Complications After Prostate Cancer Treatment Not Uncommon
Recently Updated
- Safety and Efficacy of Pembrolizumab, Radiation Therapy, and Surgery in Patients With Stage III Soft Tissue Sarcoma of the Extremity
- Antibiotics for Seven Days Noninferior for Bloodstream Infection
- Adjuvant Immunotherapy in Patients With Resected Gastric and Oesophagogastric Junction Cancer With High Risk for Recurrence (ypN+/R1) After Preoperative Chemotherapy
- Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective
- Racial, Ethnic Disparities Seen in Mortality With Early-Onset Colorectal Cancer